OpenResearchAlpha

bioRxiv · 19 Nov 2026

Zhx2 expression in the mouse brain

Sophia Miracle, Morgan L. Hofmeyer, Aleksandra G. Gorelik, Ava B. Glavine, Isabella C. Conti, Sophia V. Pavlidis, Hala Ajjawi, Erin E. Lynch, Camron D. Bryanth-index 19

0
Citations
no database records one yet
0
Citations in 2026
so far
19
Leading author's h-index
Camron D. Bryant, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • OpenAlex0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Prescription opioids like oxycodone (OXY; the active component in OxyContin™) continue to drive the ongoing opioid use disorder (OUD) epidemic due to their widespread prescription and distribution. Genetic factors influencing pharmacokinetic and pharmacodynamic properties of opioids can have profound impacts on drug response and, in turn, influence risk for OUD. We previously used quantitative trait locus (QTL) mapping and gene validation to identify zinc-finger homeobox 2 (Zhx2) loss-of-function as a quantitative trait gene and mechanism underlying increased brain concentration of oxymorphone (OMOR) following systemic administration of OXY in BALB/cJ females that was linked to increased OXY reward. To test whether we could rescue the behavioral phenotype, we overexpressed Zhx2 in the brain via retro-orbital injection of a brain-specific adeno-associated virus (AAV). We observed restricted Zhx2 expression (especially females), with more widespread expression in males. Consequently, we did not observe any significant effect of brain Zhx2 overexpression on OXY reward as measured via conditioned place preference (CPP). However, Zhx2 overexpression did protect against OXY-induced weight loss in females following a high-dose OXY regimen. Despite the effect on weight loss, Zhx2 overexpression had no effect on spontaneous or naloxone-precipitated withdrawal behaviors. We then examined native Zhx2 protein expression in the brains of the BALB/cByJ substrain (showing wild-type levels of Zhx2 expression) via immunohistochemical co-localization and found that Zhx2 is mainly expressed in neurons located in key reward, motivational, and emotion-related regions such as the hippocampus (HPC), amygdala, striatum (Str), and cerebellum. To summarize, Zhx2 overexpression via retro-orbital AAV administration was quite limited, yet had significant effects on opioid-induced weight loss. Furthermore, for the first time, we provide anatomical visualization of Zhx2 expression at the protein level in neurons vs. glia throughout multiple brain regions.

Neuroscience

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Camron D. Bryant has the highest h-index among the authors (19).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (9)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.